Home >  Blog >  TAVI: is it cost effective?

TAVI: is it cost effective?

Posted by Paul Scuffham on 1 June 2015
Paul Scuffham and Cindy Mervin are undertaking an economic evaluation of the treatment and follow-up costs to the health system for Transcatheter Aortic Valve replacement in Australia.
Author: Paul Scuffham
About: Paul Scuffham, the Foundation Professor of Health Economics at Griffith University Australia, graduated with a PhD (Economics) from the University of Otago. He has extensive experience in economic evaluation of health services and interventions such as medical devices and pharmaceuticals.
Tags: Cardiovascular Disease

Post comment
Bookmark SiteTell A FriendPrint